Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The FBIndex to Determine the Risk of Falls and Its Translation to Assistive Gait Device Care for Patients With Neuromuscular Disorders

NCT05890833 is registered in ClinicalTrials.gov with LMU Klinikum as lead sponsor.

NCT NCT05890833
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05890833 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The FBIndex to Determine the Risk of Falls and Its Translation to Assistive Gait Device Care for Patients With Neuromuscular Disorders
Lead sponsor
LMU Klinikum
Phase
Observational
Overall status
Completed
Start date
September 1, 2023
Completion date
September 9, 2024
Enrollment
30 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

facioscapulohumeral muscular dystrophies, inclusion body myositis, myasthenia gravis, myotonic dystrophy, the falls efficacy scale international, the morse fall scale